Clinical trial
Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)
NCT00202891 · Merck Sharp & Dohme LLC, Industry · Withdrawn
Key facts
| NCT number | NCT00202891 |
|---|---|
| Title | Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460) |
| Official title | Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Collaborators | Fulford India Limited |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pyoderma |
| Intervention type | Drug |
| Interventions | sisomicin |
| Enrollment | 0 |
| Start date | May 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Jun 3, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: